STOCK TITAN

[Form 4] Regional Health Properties, Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

Robert M. Thornton Jr., EVP - Corporate Strategy of Regional Health Properties, Inc. (RHE), reported multiple equity acquisitions on 08/14/2025. He received a grant of 100,000 restricted shares as an inducement to employment that vest in three equal installments on 08/14/2025, 08/14/2026 and 08/14/2027. At the effective time of a merger between SunLink Health Systems, Inc. and Regional, Mr. Thornton’s SunLink holdings converted into 1.1330 Regional common shares per 5 SunLink shares and one Series D preferred share per 5 SunLink shares, resulting in reported additions of 125,663 common shares and 110,912 Series D preferred shares. He also reports shares held indirectly through CareVest Capital, L.L.C., which he fully owns.

Robert M. Thornton Jr., EVP - Corporate Strategy di Regional Health Properties, Inc. (RHE), ha segnalato più acquisizioni di azioni il 14/08/2025. Gli è stato assegnato un premio di 100.000 azioni vincolate come incentivo all'assunzione, con maturazione in tre tranche uguali il 14/08/2025, il 14/08/2026 e il 14/08/2027. Al momento dell'efficacia della fusione tra SunLink Health Systems, Inc. e Regional, le sue partecipazioni in SunLink sono state convertite in 1,1330 azioni ordinarie Regional ogni 5 azioni SunLink e in una azione preferenziale di Serie D ogni 5 azioni SunLink, con conseguenti aumenti segnalati di 125.663 azioni ordinarie e 110.912 azioni preferenziali di Serie D. Riferisce inoltre partecipazioni detenute indirettamente tramite CareVest Capital, L.L.C., di cui è unico proprietario.

Robert M. Thornton Jr., EVP - Corporate Strategy de Regional Health Properties, Inc. (RHE), informó múltiples adquisiciones de acciones el 14/08/2025. Recibió una concesión de 100.000 acciones restringidas como incentivo por contratación, que se consolidan en tres cuotas iguales el 14/08/2025, 14/08/2026 y 14/08/2027. Al hacerse efectiva la fusión entre SunLink Health Systems, Inc. y Regional, sus participaciones en SunLink se convirtieron en 1,1330 acciones ordinarias de Regional por cada 5 acciones de SunLink y en una acción preferente Serie D por cada 5 acciones de SunLink, resultando en aumentos reportados de 125.663 acciones ordinarias y 110.912 acciones preferentes Serie D. También informa acciones mantenidas indirectamente a través de CareVest Capital, L.L.C., compañía que posee en su totalidad.

Regional Health Properties, Inc. (RHE)의 EVP - Corporate Strategy인 Robert M. Thornton Jr.는 2025년 8월 14일 여러 지분 취득을 보고했습니다. 그는 고용 유인을 위해 100,000개의 제한 주식을 부여받았으며, 이는 2025년 8월 14일, 2026년 8월 14일, 2027년 8월 14일 세 차례에 걸쳐 동일하게 베스팅됩니다. SunLink Health Systems, Inc.와 Regional의 합병이 효력 발생했을 때, 그의 SunLink 보유분은 SunLink 5주당 Regional 보통주 1.1330주SunLink 5주당 시리즈 D 우선주 1주로 전환되어 125,663주 보통주110,912주 시리즈 D 우선주의 증가가 보고되었습니다. 그는 또한 자신이 전적으로 소유한 CareVest Capital, L.L.C.를 통해 간접적으로 보유한 주식도 신고했습니다.

Robert M. Thornton Jr., EVP - Corporate Strategy de Regional Health Properties, Inc. (RHE), a déclaré plusieurs acquisitions d'actions le 14/08/2025. Il a reçu une attribution de 100 000 actions restreintes à titre d'incitation à l'embauche, qui acquièrent droit par trois tranches égales le 14/08/2025, le 14/08/2026 et le 14/08/2027. Au moment de l'entrée en vigueur de la fusion entre SunLink Health Systems, Inc. et Regional, ses participations SunLink ont été converties en 1,1330 actions ordinaires Regional pour 5 actions SunLink et en une action préférentielle Série D pour 5 actions SunLink, entraînant des augmentations déclarées de 125 663 actions ordinaires et de 110 912 actions préférentielles Série D. Il déclare également des actions détenues indirectement via CareVest Capital, L.L.C., qu'il possède intégralement.

Robert M. Thornton Jr., EVP - Corporate Strategy von Regional Health Properties, Inc. (RHE), meldete am 14.08.2025 mehrere Eigenkapitalerwerbe. Ihm wurde als Einstellungsanreiz ein Zuschuss von 100.000 eingeschränkten Aktien gewährt, die in drei gleichen Tranchen am 14.08.2025, 14.08.2026 und 14.08.2027 vesten. Zum Zeitpunkt des Wirksamwerdens der Fusion zwischen SunLink Health Systems, Inc. und Regional wurden seine SunLink-Beteiligungen in 1,1330 Regional-Stammaktien pro 5 SunLink-Aktien und in eine Series-D-Vorzugsaktie pro 5 SunLink-Aktien umgewandelt, was zu gemeldeten Zugängen von 125.663 Stammaktien und 110.912 Series-D-Vorzugsaktien führte. Er meldet außerdem indirekt gehaltene Anteile über CareVest Capital, L.L.C., das er vollständig besitzt.

Positive
  • 100,000 restricted shares awarded as an employment inducement with a clear three-year vesting schedule
  • Post-merger conversion provided the reporting person with 125,663 common shares and 110,912 Series D preferred shares
  • Full disclosure of indirect holdings through CareVest Capital, L.L.C., including identification of ownership structure
Negative
  • None.

Insights

TL;DR: Insider received significant restricted stock grant and conversion shares tied to a merger, increasing both direct and indirect holdings.

The Form 4 documents a multi-part acquisition: a 100,000-share restricted stock grant tied to employment and conversion of former SunLink holdings into both common and Series D preferred shares at the stated conversion ratio. The transactions increase Mr. Thornton’s economic and voting exposure to Regional via direct ownership and indirect ownership through CareVest. For investors, the filing signals management alignment through equity-based compensation and post-merger share distribution, but contains no financial performance metrics or indications of planned sales.

TL;DR: Routine insider reporting of employment inducement and merger-related conversions; standard disclosure of indirect holdings.

The disclosure correctly identifies the inducement grant with vesting schedule and details the merger conversion mechanics into common and Series D preferred shares. It also discloses indirect ownership via CareVest and an IRA, fulfilling Section 16 reporting requirements. There are no amendments, dispositions, or sales reported here, and no governance red flags are evident from the form itself.

Robert M. Thornton Jr., EVP - Corporate Strategy di Regional Health Properties, Inc. (RHE), ha segnalato più acquisizioni di azioni il 14/08/2025. Gli è stato assegnato un premio di 100.000 azioni vincolate come incentivo all'assunzione, con maturazione in tre tranche uguali il 14/08/2025, il 14/08/2026 e il 14/08/2027. Al momento dell'efficacia della fusione tra SunLink Health Systems, Inc. e Regional, le sue partecipazioni in SunLink sono state convertite in 1,1330 azioni ordinarie Regional ogni 5 azioni SunLink e in una azione preferenziale di Serie D ogni 5 azioni SunLink, con conseguenti aumenti segnalati di 125.663 azioni ordinarie e 110.912 azioni preferenziali di Serie D. Riferisce inoltre partecipazioni detenute indirettamente tramite CareVest Capital, L.L.C., di cui è unico proprietario.

Robert M. Thornton Jr., EVP - Corporate Strategy de Regional Health Properties, Inc. (RHE), informó múltiples adquisiciones de acciones el 14/08/2025. Recibió una concesión de 100.000 acciones restringidas como incentivo por contratación, que se consolidan en tres cuotas iguales el 14/08/2025, 14/08/2026 y 14/08/2027. Al hacerse efectiva la fusión entre SunLink Health Systems, Inc. y Regional, sus participaciones en SunLink se convirtieron en 1,1330 acciones ordinarias de Regional por cada 5 acciones de SunLink y en una acción preferente Serie D por cada 5 acciones de SunLink, resultando en aumentos reportados de 125.663 acciones ordinarias y 110.912 acciones preferentes Serie D. También informa acciones mantenidas indirectamente a través de CareVest Capital, L.L.C., compañía que posee en su totalidad.

Regional Health Properties, Inc. (RHE)의 EVP - Corporate Strategy인 Robert M. Thornton Jr.는 2025년 8월 14일 여러 지분 취득을 보고했습니다. 그는 고용 유인을 위해 100,000개의 제한 주식을 부여받았으며, 이는 2025년 8월 14일, 2026년 8월 14일, 2027년 8월 14일 세 차례에 걸쳐 동일하게 베스팅됩니다. SunLink Health Systems, Inc.와 Regional의 합병이 효력 발생했을 때, 그의 SunLink 보유분은 SunLink 5주당 Regional 보통주 1.1330주SunLink 5주당 시리즈 D 우선주 1주로 전환되어 125,663주 보통주110,912주 시리즈 D 우선주의 증가가 보고되었습니다. 그는 또한 자신이 전적으로 소유한 CareVest Capital, L.L.C.를 통해 간접적으로 보유한 주식도 신고했습니다.

Robert M. Thornton Jr., EVP - Corporate Strategy de Regional Health Properties, Inc. (RHE), a déclaré plusieurs acquisitions d'actions le 14/08/2025. Il a reçu une attribution de 100 000 actions restreintes à titre d'incitation à l'embauche, qui acquièrent droit par trois tranches égales le 14/08/2025, le 14/08/2026 et le 14/08/2027. Au moment de l'entrée en vigueur de la fusion entre SunLink Health Systems, Inc. et Regional, ses participations SunLink ont été converties en 1,1330 actions ordinaires Regional pour 5 actions SunLink et en une action préférentielle Série D pour 5 actions SunLink, entraînant des augmentations déclarées de 125 663 actions ordinaires et de 110 912 actions préférentielles Série D. Il déclare également des actions détenues indirectement via CareVest Capital, L.L.C., qu'il possède intégralement.

Robert M. Thornton Jr., EVP - Corporate Strategy von Regional Health Properties, Inc. (RHE), meldete am 14.08.2025 mehrere Eigenkapitalerwerbe. Ihm wurde als Einstellungsanreiz ein Zuschuss von 100.000 eingeschränkten Aktien gewährt, die in drei gleichen Tranchen am 14.08.2025, 14.08.2026 und 14.08.2027 vesten. Zum Zeitpunkt des Wirksamwerdens der Fusion zwischen SunLink Health Systems, Inc. und Regional wurden seine SunLink-Beteiligungen in 1,1330 Regional-Stammaktien pro 5 SunLink-Aktien und in eine Series-D-Vorzugsaktie pro 5 SunLink-Aktien umgewandelt, was zu gemeldeten Zugängen von 125.663 Stammaktien und 110.912 Series-D-Vorzugsaktien führte. Er meldet außerdem indirekt gehaltene Anteile über CareVest Capital, L.L.C., das er vollständig besitzt.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
THORNTON ROBERT M JR

(Last) (First) (Middle)
C/O REGIONAL HEALTH PROPERTIES, INC.
1050 CROWN POINTE PARKWAY, SUITE 720

(Street)
ATLANTA GA 30338

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
REGIONAL HEALTH PROPERTIES, INC [ RHEP ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
EVP - Corporate Strategy
3. Date of Earliest Transaction (Month/Day/Year)
08/14/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 08/14/2025 A(1) 100,000 A $0 100,000 D
Common Stock 08/14/2025 A 125,663 A (2) 125,663 I See Footnote(3)
Common Stock 08/14/2025 A 1,133 A (2) 1,133 I By IRA
Series D 8% Cumulative Conver Redeemable Preferred Shares 08/14/2025 A 110,912 A (2) 110,912 I See Footnote(3)
Series D 8% Cumulative Conver Redeemable Preferred Shares 08/14/2025 A 1,000 A (2) 1,000 I By IRA
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Grant of restricted stock that was awarded to the Reporting Person as an inducement to his employment with Regional Health Properties, Inc. ("Regional"). The restricted stock will vest in three substantially equal installments on August 14, 2025, August 14, 2026 and August 14, 2027.
2. At the effective time of the merger (the "Effective Time") between SunLink Health Systems, Inc. ("SunLink") and Regional, each five shares of common stock, no par value per share, of SunLink held by the Reporting Person prior to the Effective Time were converted into the right to receive (i) 1.1330 shares of common stock, no par value per share, of Regional, and (ii) one share of Series D 8% Cumulative Convertible Redeemable Participating Preferred Shares, no par value per share, of Regional.
3. Owned by CareVest Capital, L.L.C. ("CareVest"). Mr. Thornton owns 100% of the outstanding voting shares of CareVest and is reporting CareVest's total direct holdings of Regional shares.
/s/ Robert M. Thornton Jr. 08/18/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transactions did Robert M. Thornton Jr. report on Form 4 for RHE?

He reported a 100,000 restricted stock grant, conversion of SunLink shares into 125,663 common shares and 110,912 Series D preferred shares, and small IRA-held amounts on 08/14/2025.

When do the restricted shares awarded to Mr. Thornton vest?

The restricted stock vests in three substantially equal installments on 08/14/2025, 08/14/2026 and 08/14/2027.

How were SunLink shares converted at the Effective Time of the merger?

Each five SunLink common shares converted into 1.1330 Regional common share and one Series D preferred share of Regional.

Does Mr. Thornton report indirect holdings and how are they held?

Yes. Certain holdings are reported as indirect via CareVest Capital, L.L.C., of which Mr. Thornton owns 100% of the voting shares.

Were any dispositions or sales reported in this Form 4?

No. The Form 4 discloses only acquisitions and conversions; no dispositions or sales are reported.
Regional Health

NYSE:RHE

RHE Rankings

RHE Latest News

RHE Latest SEC Filings

RHE Stock Data

5.04M
1.61M
General Medical and Surgical Hospitals
Lessors of Real Property, Nec
Link
US
ATLANTA